MarketsStocksDRREDDY
DR

Dr Reddys Laboratories Ltd

NSE: DRREDDYBSE: 500124Healthcare
Download Research Report7-page PDF
1,275.00
-0.25%
NSE · auto-updates while market open
Prev Close
₹1,320.90
Day High
₹1,293.70
Day Low
₹1,270.00
Mkt Cap
₹1.07 L Cr
P / E
25.6
P / B
2.8
ROE
11.6%
52W High
₹1,379.70
52W Low
₹1,148.40
Key Metrics
Market Cap
₹1.07 L Cr
P / E
25.62
P / B
2.81
EV / EBITDA
16.99
ROCE
14.1%
ROE
11.6%
Debt / Equity
0.17
Book Value
₹453.79
EPS
₹50.41
Div Yield
1.3%
Face Value
₹1
Promoter Holding
26.6%
Revenue · ₹ Cr
18k
FY20
19k
FY21
22k
FY22
25k
FY23
28k
FY24
33k
FY25
34k
FY26
Net Profit · ₹ Cr
2.0k
FY20
2.0k
FY21
2.2k
FY22
4.5k
FY23
5.6k
FY24
5.7k
FY25
4.2k
FY26
EPS · ₹ per share
₹122.2
FY20
₹117.7
FY21
₹131.6
FY22
₹271.5
FY23
₹335.2
FY24
₹67.9
FY25
₹50.4
FY26
P / E Ratio · price ÷ TTM EPS
11020293821780-27Jun 21Feb 23Oct 24Jun 26
P/E 25.3×Median 5.1×TTM EPS
Q1 2026 snapshot
Sales
₹8.02K Cr
Operating profit
-
OPM
-
Net profit
₹221 Cr
EPS
₹2.65
Scorecard · 7 axes
Quality
Strong
75/100
Valuation
Avg
25.6×
Growth
Good
+14.7%
Profitability
Avg
12.8%
Performance
Bad
-1.0%
Entry Point
Weak
92%
Red Flags
Strong
0 flags
Shareholding Pattern
26.6%Promoter
Promoter26.6%
FII33.1%
DII30.7%
Public9.6%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue8,381.29,050.58,862.49,152.29,022.28,021.8
Net Profit1,404.21,586.71,409.91,336.81,189.6221.3
NPM %16.8%17.5%15.9%14.6%13.2%2.8%
AlertPre-trade